UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1O~Q
[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
For the period ended June 30, 1996
or
[] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
For the transition period from ____ to _____
Commission File Number 0-14724
ARNOX CORPORATION
Delaware 06-1094094
(state or other jurisdiction of (IRS Employer
incorporation of organization) identification No.)
1612 N. Osceola Avenue
Clearwater, Florida 34615
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, Including area code: (813)
443-3434
Indicate by check mark whether the Registrant (1) has
filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the
Registrant was required to file such reports).
Yes X No. ______
APPLICABLE ONLY TO REGISTRAINTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING ThE PRECEDING FIVE YEARS
Indicate by check mark whether the Registrant has
filed all documents and reports required to be filed by
Sections 12, 13 or15(d) of the Securities Exchange Act of
1934 subsequent to thedistribution of securities under a
plan confirmed by a court.
N/A Yes __ No ___
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest
practicable date.
Common Stock 3,439,247 shares.
PART 1-FINANCIAL INFORMATION
Item 1. Financial Statements.
ARNOX CORPORATION
(a Dormant State Company)
for the quarter ending June 30, 1996
Assets Organization Cost $ 0.00
Totals Assets 0.00
Liabilities and Shareholder's Equity
Stockholders' Equity
Common Stock par value at $0.00001 per share
10,000,000 shares authorized,3,439,247 shares
issued and outstanding 0.00
Additional Paid in Capital 3,417.00
Deficit accumulated during development stage (3,417.00)
Total Shareholders' Equity 0.00
Total Liabilities and Shareholders Equity $ 0.00
ARNOX CORPORATION
(a Dormant State Company)
Income Statements for the quarter ending June 30, 1996
1996
Revenues and Expenses $ 0.00
ARNOX CORPORATION
(a Dormant State Company)
Statements of Shareholder's Equity
for the quarter ending June 30, 1996
Common Stock
(3,439,247 shares issued & outstanding) $ 0.00
Additional Paid in Capital $ 0.00
Accumulated Deficit $ 0.00
Balance Jan 1 $ 0.00
Net Income/(loss) for the year $(3,417.00)
Balance June 30, 1996 $ 0.00
Item 2. Management Discussion and Analysis of Financial
Condition and Results of Operations.
The Registrant was incorporated on October 17,1983 in the
State of Delaware. The Company's business consisted
of developing, manufacturing, marketing and licensing
fire retardant products. These fire retardant products
were marketed under the trade name Arnox FR. The Company's
fire retardant chemicals were used to treat corrugated
packaging board for military and commercial applications,
for particle board, chip board, and paneling in mobile
homes. The Company's shares were traded on the NASDAQ
exchange until April 25, 1989. The Company was most
closely aligned to the lumber industry because its
products were used to treat lumber and products,
such as corrugated board, which are derived from lumber. On
September 11, 1989, the Registrant filed a petition, No. 89-
97155, in the U.S. Bankruptcy Court for the District of
New Jersey. This was converted from a Chapter 11 to a
Chapter 7 petition on December 18,1989. This bankruptcy
proceeding endured for four years and ten months. On
July 12, 1994, the Registrant's Petition was declared
closed and the Trustee was discharged. Since July 12,
1994, the Registrant has been totally inactive.
ARNOX does not accrue any liability for the expenses
incurred with Capston's activities to bring ARNOX current
with all of its reporting and filings requirements or in
connection with services rendered prior to closing of the a
business combination. Moreover, any such reimbursement will
be subject to the express approval of the owners of the
business opportunity acquired by the Company.
This interim financial statement reflects all adjustments
which are, in the management, necessary to a fair statement
of the Company's financial position and results of
operations for this period.
PART II-OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 2. Changes in Securities
None.
Item 3. Defaults Upon Senior Securities
Not Applicable
Item 4. Submission of matters to a vote of Security Holders.
On June 13, 1996, Proxy Statements were mailed to all
security holders. These asked the stockholders to do the
following: (1) ratify the act of reinstating the original
charter of ARNOX Corporation; (2)authorize Capston Network
Co. and its authorized representatives, Ms. Sally Fonner and
Norman Sirak, to file 10 K and 10 Q reports on behlafof the
Company and bring it current with its reporting requirement;
(3)authorize Capston Network Co. and its authorized
representatives to seek out a qualified purchaser for ninety
percent of the company's issued stock; (4)approve in
principle a restructuring of Arnox whereby existing
shareholders would accept a ten-for one reverse split,
simultaneous with the issuance of a ninety percent block of
stock to a qualified purchaser; (5)approve of Ms. Sally
Fonner acting on behalf of the company for a two year term
or until a qualified purchaser can be found that can imbue
the company with new managment, whichever happens first;
and (6)approve of moving the company's place of business to
St. Petersburg, Florida.
The deadline for submitting proxy statements is July 3,
1996, so no official result can be reported within this
quarter. However, returned votes were heavily in favor of
approving all of the above matters, at period's closing.
Item 5. Market for Registrant's Common Equity
There is no established public trading market for the
Registrant's securities. The Company has no operations and
no income.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d)
of the Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
ARNOX Corporation Date: 03/13/97
By___________________
Sally Fonner,Director,
President and Chief
Financial Officer
Pursuant to the requirements of the Securities
Exchange Act of 1934 this report has been signed below
by the following person on behalf of the Registrant and
in the capacities and on the date indicated.
Date: 03/13/97
By__________________
Sally Fonner, Director,
President and Chief
Financial Officer
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-END> JUN-30-1996
<CASH> 0
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 0
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 0
<CURRENT-LIABILITIES> 0
<BONDS> 0
0
0
<COMMON> 3,439,247
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 0
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 3,417
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,417)
<EPS-PRIMARY> 0
<EPS-DILUTED> 0
</TABLE>
